DICE Therapeutics CEO J Judice's 2021 pay jumps 774% to $5.6M
DICE Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 26, 2022
DICE Therapeutics reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at DICE Therapeutics received on average a compensation package of $3.3M, a 436% increase compared to previous year.
Average pay of disclosed executives at DICE Therapeutics
J. Kevin Judice, Chief Executive Officer, received $5.6M in total, which increased by 774% compared to 2020. 57% of Judice's compensation, or $3.2M, was in option awards. Judice also received $300K in non-equity incentive plan, $465K in salary, as well as $1.6M in stock awards.
Scott Robertson, Chief Business and Financial Officer, received a compensation package of $2.4M, which increased by 294% compared to previous year. 57% of the compensation package, or $1.4M, was in option awards.
Timothy Lu, Chief Medical Officer, earned $2M in 2021.
Related executives
You may also like
Source: SEC filing on April 26, 2022.